Treatment is with topical corticosteroids and mydriatics.
These patients should be evaluated by an ophthalmologist. There is an as yet unsubstantiated concern that widespread use of rifabutin for MAC prophylaxis will promote rifampin resistance to M. tuberulosis . Rifampin and rifabutin are related drugs, but in vitro activity and clinical trials show that rifabutin is preferred for M. avium and rifampin is preferred for M. tuberulosis . Uveitis requires immediate discontinuation of drug and ophthalmology consult. The Johns Hopkins University on behalf of its Division of Infectious Diseases and AIDS Service.